Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2-Deoxy-D-glucose for Rhinovirus Pre-exposure Prophylaxis (Human Rhinovirus Challenge Study)
2023-509311-91-01Phase 2Completed
- Sponsor
- G.ST Antivirals
- Start
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in rhinoviral infection comparing 2-deoxy-D-glucose with Placebo (2 arms). Primary endpoint: Rate of rhinovirus-associated illness. Started Feb 2024; status: completed.
02
Drugs
2-deoxy-d-glucose
03
Conditions
rhinoviral infection
Beyond the preview
Go deeper on 2023-509311-91-01.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-509311-91-01.